zadnja posodobitev :
19/11/2024
Infostab
Seznami
Seznami
Poiščite združljivosti
Tabela združljivosti Y-strani
Viri
raziskovalne skupine
valistab
poster
Povezave
sponzorji
Avtor
Navodilo za uporabo
Newsletter
Viri 934
Tip :
časopis
internet povezava :
http://www.ijpc.com/Abstracts/Abstract.cfm?ABS=452
raziskovalne skupine :
Nagoya - Meijo University, Faculty of Pharmacy
Avtor :
Inagaki K, Kambara M, Mizuno M, Okuda J, Gill MA, Nishida M.
Naslov :
Compatibility and stability of ranitidine hydrochloride with six cephalosporins during simulated Y-site administration.
Référence :
Int J Pharm Compound ; 2: 318-321. 1998
Raven dokazov :
Fizikalna stabilnost :
Kemična stabilnost :
Druge metode :
Komentarji :
Seznami
Cefmenoxime
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Cefoperazone sodium
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Ceftizoxime sodium
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Cefuzonam
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Moxalactam
20 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Ranitidine hydrochloride
1 mg/ml
+
Cefmenoxime
20 mg/ml
+
1 mg/ml
+
Cefoperazone sodium
20 mg/ml
+
1 mg/ml
+
Ceftizoxime sodium
20 mg/ml
+
1 mg/ml
+
Cefuzonam
20 mg/ml
+
1 mg/ml
+
Moxalactam
20 mg/ml
+
25°C
Ranitidine hydrochloride
0,5 mg/ml
Moxalactam
10 mg/ml
2
25°C
Ranitidine hydrochloride
0,5 mg/ml
Ceftizoxime sodium
10 mg/ml
4
25°C
Ranitidine hydrochloride
0,5 mg/ml
Cefoperazone sodium
10 mg/ml
4
25°C
Ranitidine hydrochloride
0,5 mg/ml
Cefmenoxime
10 mg/ml
4
25°C
Ranitidine hydrochloride
0,5 mg/ml
Cefuzonam
10 mg/ml
4
Mentions Légales